In the last trading session, 32.23 million shares of the Hims & Hers Health Inc (NYSE:HIMS) were traded, and its beta was 1.08. Most recently the company’s share price was $19.32, and it changed around -$1.53 or -7.34% from the last close, which brings the market valuation of the company to $3.91B. HIMS currently trades at a discount to its 52-week high of $30.44, offering almost -57.56% off that amount. The share price’s 52-week low was $7.40, which indicates that the current value has risen by an impressive 61.7% since then. We note from Hims & Hers Health Inc’s average daily trading volume that its 10-day average is 29.94 million shares, with the 3-month average coming to 12.17 million.
Hims & Hers Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.31. If we narrow it down even further, the data shows that 0 out of 15 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 8 recommended HIMS as a Hold, whereas 4 deemed it a Buy, and 1 rated it as Underweight. Hims & Hers Health Inc is expected to report earnings per share of 0.22 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS has showed a red trend with a performance of -7.34% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 30.44 on recent trading dayincreased the stock’s daily price by 36.53%. The company’s shares are currently up 117.08% year-to-date, but still down -17.47% over the last five days. On the other hand, Hims & Hers Health Inc (NYSE:HIMS) is -10.39% down in the 30-day period. We can see from the shorts that 33.84 million shares have been sold at a short interest cover period of 2.66 day(s).
The consensus price target as assigned by Wall Street analysts is $23, which translates to bulls needing to increase their stock price by 16.0% from its current value. Analyst projections state that HIMS is forecast to be at a low of $8 and a high of $28.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Hims & Hers Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 32.60 percent over the past six months and at a 600.00% annual growth rate that is well above the industry average of 22.30%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 310.31% in revenue this quarter, and will report an increase of 76.30% in the next quarter. The year-over-year growth rate is expected to be 67.54%, up from the previous year.
Consensus estimates provided by 11 financial analysts predict the company will bring in an average of 469.48M in revenue for the current quarter. 6 analysts expect Hims & Hers Health Inc to make 480.43M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 246.62M and 278.17M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 90.37%. Forecasts for the next quarter put sales growth at 72.71%.
HIMS Dividends
Hims & Hers Health Inc’s next quarterly earnings report is expected to be released in December.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 11.39% of Hims & Hers Health Inc shares, and 66.16% of them are in the hands of institutional investors. The stock currently has a share float of 74.67%. Hims & Hers Health Inc stock is held by 419.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 7.7166% of the shares, which is about 16.47 million shares worth $332.55 million.
BLACKROCK INC., with 6.8278% or 14.57 million shares worth $294.25 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
